# Oral Salt and Water to Prevent Contrast Nephropathy

> **NCT02084771** · PHASE4 · WITHDRAWN · sponsor: **Ottawa Hospital Research Institute**

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DRUG:** Intravenous Saline
- **BIOLOGICAL:** Oral Salt and Water

## Key facts

- **NCT ID:** NCT02084771
- **Lead sponsor:** Ottawa Hospital Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-10
- **Primary completion:** 2015-12
- **Final completion:** 2016-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The recruitment rate was very slow, and it was concluded that it was not feasible to do this trial.
- **Last updated:** 2016-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02084771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02084771, "Oral Salt and Water to Prevent Contrast Nephropathy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02084771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*